This review covers bremelanotide's mechanism for female sexual function: central melanocortin MC3R/MC4R activation in hypothalamic and limbic sexual arousal circuits, with evidence for enhancing desire, arousal, and satisfaction.
Key findingBremelanotide activates female sexual function through MC3R/MC4R in hypothalamic/limbic sexual circuits, enhancing desire and arousal through dopamine
What the researchers found
Bremelanotide activates female sexual function through MC3R/MC4R in hypothalamic/limbic sexual circuits, enhancing desire and arousal through dopaminergic and oxytocinergic pathway modulation — the comprehensive CNS mechanism supporting its clinical development for female HSDD.
Why it matters
Relevant for pt-141, melanotan, sexual-health.
How the study worked
review study on pt-141, melanotan.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Bremelanotide: an overview of preclinical CNS effects on female sexual function.
The journal of sexual medicine, 4 Suppl 4, 269-79
Citation
Pfaus, James; Giuliano, François; Gelez, Hélène. (2007). Bremelanotide: an overview of preclinical CNS effects on female sexual function.. The journal of sexual medicine, 4 Suppl 4, 269-79.